Quidel Corp
NASDAQ:QDEL

Watchlist Manager
Quidel Corp Logo
Quidel Corp
NASDAQ:QDEL
Watchlist
Price: 46.03 USD -1.88%
Market Cap: 3.1B USD
Have any thoughts about
Quidel Corp?
Write Note

Operating Margin
Quidel Corp

3.7%
Current
27%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
3.7%
=
Operating Profit
103.7m
/
Revenue
2.8B

Operating Margin Across Competitors

Country US
Market Cap 3.1B USD
Operating Margin
4%
Country JP
Market Cap 7T JPY
Operating Margin
28%
Country CH
Market Cap 37.9B CHF
Operating Margin
13%
Country DK
Market Cap 178.7B DKK
Operating Margin
27%
Country US
Market Cap 16.1B USD
Operating Margin
17%
Country KR
Market Cap 10.3T KRW
Operating Margin
-245%
Country CN
Market Cap 49B CNY
Operating Margin
45%
Country US
Market Cap 6.5B USD
Operating Margin
32%
Country CA
Market Cap 6.4B USD
Operating Margin
4%
Country US
Market Cap 5.7B USD
Operating Margin
12%
Country UK
Market Cap 4.6B GBP
Operating Margin
13%
No Stocks Found

Quidel Corp
Glance View

Market Cap
3.1B USD
Industry
Health Care

Quidel Corporation, a player in the diagnostic healthcare industry, has steadily navigated the labyrinth of medical innovation, carving out a niche in rapid diagnostic testing. Born out of a mission to streamline the process of disease detection, Quidel has leveraged biotechnology to develop fast, reliable diagnostic solutions that address widespread health issues. This company’s arsenal includes tests for infectious diseases, reproductive health, and autoimmune disorders—each meticulously designed to expedite the diagnostic process while maintaining a stringent commitment to accuracy. By fostering partnerships with healthcare providers and aligning with technological advancements, Quidel has positioned itself as indispensable in the clinic setting, where swift decision-making can significantly impact patient care. At the heart of Quidel's business model is its focus on providing tangible value to both healthcare professionals and patients. The company generates revenue primarily through the sale of its diagnostic products, which are utilized in settings ranging from small clinics to large hospital networks. Quidel's innovative platforms, like the Sofia and Solana systems, are lauded for their efficiency and ease of use, attributes that resonate particularly well in medical environments under pressure to deliver fast and effective results. By effectively converting scientific expertise into practical and user-friendly applications, Quidel not only enhances patient outcomes but also fortifies its financial standing within the competitive landscape of medical diagnostics.

QDEL Intrinsic Value
65.88 USD
Undervaluation 30%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
3.7%
=
Operating Profit
103.7m
/
Revenue
2.8B
What is the Operating Margin of Quidel Corp?

Based on Quidel Corp's most recent financial statements, the company has Operating Margin of 3.7%.